InvestorsHub Logo
Followers 4
Posts 1028
Boards Moderated 0
Alias Born 08/08/2017

Re: brooklyn13 post# 48451

Friday, 04/19/2019 7:43:03 AM

Friday, April 19, 2019 7:43:03 AM

Post# of 55190
MA?

To my mind, here's the difference: a scientist seeking to determine which cannabinoids can cure ailments by extracting compounds, running them through trials... and then developing medicine based off of results... vs. a scientist knowing what cannabinoids he needs for his medicine, and using an engineered plant that contains a boatload of them for extraction...

Which scenario works best in terms of efficiency and effectiveness? This ship hasn't sailed... little faith is required to fill the evidence gap... some of the evidence we have is our (past?) relationship with Anandia prior to them being bought out by ACB... we are a plant biotech co. ...let's see if KeyGene can amplify our portfolio... in any case- it's our backpocket

Our endgame is BT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News